Not Tagged
Not Tagged
['sarcoma']
 md presents efficacy and safety for ny-eso-1 lete-cel - in myxoid/round cell lipo- promising responses and expected safety profile! #immunotherapy #sarcoma #asco22 
Director, Sarcoma Oncology, @CUCancerCenter. Immunotherapy translational researcher. Tweets reflect my own opinions. #ASCO22 FCOI: https://t.co/0A1ZNKFLZn